Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 450, doi. 10.1634/theoncologist.2016-0444
- By:
- Publication type:
- Article
Works by Tschernichovsky, Roi
Results: 7
1
2
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 461, doi. 10.1007/s11060-024-04562-0
- By:
- Publication type:
- Article
3
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 3, p. 483, doi. 10.1007/s11060-021-03911-7
- By:
- Publication type:
- Article
4
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1383, doi. 10.1093/neuonc/noab049
- By:
- Publication type:
- Article
5
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1589, doi. 10.1111/1759-7714.14902
- By:
- Publication type:
- Article
6
Stereotactic Radiotherapy to the Prostate and Pelvic Lymph Nodes for High-Risk and Very High-Risk Prostate Cancer in a Setting with a Hydrogel Spacer: A Toxicity Report.
- Published in:
- Cancers, 2025, v. 17, n. 12, p. 1970, doi. 10.3390/cancers17121970
- By:
- Publication type:
- Article
7
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor.
- Published in:
- Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae154
- By:
- Publication type:
- Article